Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anebulo Pharmaceuticals (ANEB)
NASDAQ:ANEB
RESEARCH TOOLSreports
Anebulo Pharmaceuticals (ANEB) Stock Price & Analysis
16 Followers
ANEB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.62 - $4.05
Previous Close$3
Volume7.16K
Average Volume (3M)5.75K
Market Cap
$78.06M
Enterprise Value$71.16M
Total Cash (Recent Filing)$6.64M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-7.3
Beta1.12
Next Earnings
Sep 18, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding25,933,217
10 Day Avg. Volume4,201
30 Day Avg. Volume5,752
Standard Deviation0.23
R-Squared0.05
Alpha0.00112
Financial Highlights & Ratios
Price to Book (P/B)12.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-10.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.82
Forecast
1Y Price Target
$5.00Price Target Upside66.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Anebulo Pharmaceuticals News
Ownership Overview
84.91% Insiders
0.16% Mutual Funds
3.08% Other Institutional Investors
11.85% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ANEB FAQ
What was Anebulo Pharmaceuticals’s price range in the past 12 months?
Anebulo Pharmaceuticals lowest stock price was $1.62 and its highest was $4.05 in the past 12 months.
What is Anebulo Pharmaceuticals’s market cap?
Currently, no data Available
When is Anebulo Pharmaceuticals’s upcoming earnings report date?
Anebulo Pharmaceuticals’s upcoming earnings report date is Sep 18, 2024 which is in 130 days.
How were Anebulo Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Anebulo Pharmaceuticals overvalued?
According to Wall Street analysts Anebulo Pharmaceuticals’s price is currently Undervalued.
Does Anebulo Pharmaceuticals pay dividends?
Anebulo Pharmaceuticals does not currently pay dividends.
What is Anebulo Pharmaceuticals’s EPS estimate?
Anebulo Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anebulo Pharmaceuticals have?
Anebulo Pharmaceuticals has 25,933,216 shares outstanding.
What happened to Anebulo Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Anebulo Pharmaceuticals?
Currently, no hedge funds are holding shares in ANEB
---
Anebulo Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.43%
12-Months-Change
Fundamentals
Return on Equity
-95.37%
Trailing 12-Months
Asset Growth
-55.59%
Trailing 12-Months
Company Description
Anebulo Pharmaceuticals
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
---
ANEB Stock 12 Month Forecast
Average Price Target
$5.00
▲(66.11% Upside)
Technical Analysis
---